Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Operating Expenses (2016 - 2025)

Bio-Techne has reported Operating Expenses over the past 17 years, most recently at $136.8 million for Q4 2025.

  • Quarterly results put Operating Expenses at $136.8 million for Q4 2025, down 6.59% from a year ago — trailing twelve months through Dec 2025 was $675.8 million (up 15.59% YoY), and the annual figure for FY2025 was $688.0 million, up 22.2%.
  • Operating Expenses for Q4 2025 was $136.8 million at Bio-Techne, down from $140.5 million in the prior quarter.
  • Over the last five years, Operating Expenses for TECH hit a ceiling of $222.7 million in Q2 2025 and a floor of $99.6 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $126.3 million (2022), compared with a mean of $133.3 million.
  • Biggest five-year swings in Operating Expenses: surged 45.08% in 2021 and later dropped 8.02% in 2023.
  • Bio-Techne's Operating Expenses stood at $121.3 million in 2021, then dropped by 4.84% to $115.5 million in 2022, then rose by 20.02% to $138.6 million in 2023, then increased by 5.69% to $146.5 million in 2024, then decreased by 6.59% to $136.8 million in 2025.
  • The last three reported values for Operating Expenses were $136.8 million (Q4 2025), $140.5 million (Q3 2025), and $222.7 million (Q2 2025) per Business Quant data.